Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer

Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas

(2012) Renê Gerhard et al.   BREAST

Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells

(2012) Hsing-Chen Tsai et al.   CANCER CELL

Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype

(2012) Shaolei Lu et al.   MODERN PATHOLOGY

Predicted expansion of the claudin multigene family

(2011) Katsuhiko Mineta et al.   FEBS LETTERS

Genome-wide profiling of DNA methylation in human cancer cells

(2011) Katsumi Ogoshi et al.   GENOMICS

Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion

(2010) Mariola Kulawiec et al.   CANCER BIOLOGY & THERAPY

Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis

(2010) A. M. Szasz et al.   CLINICAL & EXPERIMENTAL METASTASIS

Claudins: unlocking the code to tight junction function during embryogenesis and in disease

(2010) IR Gupta et al.   CLINICAL GENETICS

Azacitidine for the treatment of myelodysplastic syndrome

(2009) Vince D Cataldo et al.   Expert Review of Anticancer Therapy

Azacytidine causes complex DNA methylation responses in myeloid leukemia

(2008) C. Stresemann et al.   MOLECULAR CANCER THERAPEUTICS